title: Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice.
abstract: In an attempt to generate transgenic mice modeling Alzheimer-type amyloidogenesis, the COOH-terminal 103 residue human APP segment was expressed in brain regions known to be vulnerable in AD. Transfected cells overexpressing this transgene were previously shown to develop intracytoplasmic inclusions that were immunoreactive with antibodies to the APP COOH-terminus. Transgenic C57B6/SJL mice produced transgene-coded mRNA in their brains at levels up to sixfold above endogenous APP, most abundantly within cortical and hippocampal pyramidal neurons. Immunocytochemistry with anti-A beta antibodies revealed occasional structures that resembled diffuse amyloid, but which could not be detected on serial sections. Immunolabeling with antibodies to APP regions NH2-terminal to the transgene-coded domain revealed elevated immunoreactivity within perikarya and neurites in regions expressing the highest transgene and endogenous APP mRNA levels, similar to observations previously reported within vulnerable neurons in AD brain. However, subsequent breeding revealed that this phenotype segregated with the B6/SJL background rather than the transgene, thus emphasizing the importance of genetic background to observations of putative AD-type pathology in transgenic animals.
authors: Upjohn Company, Kalamazoo, MI 49001, USA.
authors: S M
authors: SM
authors: Ali
authors: S L
authors: SL
authors: Siedlak
authors: P A
authors: PA
authors: Gonzalez-DeWhitt
authors: R A
authors: RA
authors: Altman
authors: J M
authors: JM
authors: Glendening
authors: D E
authors: DE
authors: Lowery
authors: M J
authors: MJ
authors: Savage
authors: H G
authors: HG
authors: Polites
authors: G
authors: G
authors: Perry
authors: B D
authors: BD
authors: Greenberg
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics / Q000473:pathology; D016564:Amyloid beta-Protein Precursor / Q000096:biosynthesis / Q000235:genetics*; D000686:Amyloidosis / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D000818:Animals; D001483:Base Sequence; D001923:Brain Chemistry / Q000235:genetics*; D004247:DNA / Q000096:biosynthesis; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008845:Microinjections; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000096:biosynthesis; D013045:Species Specificity; D019076:Transgenes
chemical_list: D016564:Amyloid beta-Protein Precursor; D012333:RNA, Messenger; D004247:DNA